USE OF PEMIROLAST

• 收藏
• 分享

专利权人:

RSPR Pharma AB

发明人:

Johan RAUD,Carl-Johan DALSGAARD,Goran TORNLING

申请号：

US15136519

公开号：

US20170112837A1

申请日:

2016.04.22

申请国别(地区):

US

年份:

2017

代理人:

摘要：

According to the invention there is provided a method for the treatment of airway hyperresponsiveness, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof, to a patient in need of such treatment. Suitable lower doses of pemirolast are least about 110 mg per day.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/